News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Rhythm Pharmaceuticals, Inc.
< Previous
1
2
Next >
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
January 12, 2024
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640
January 04, 2024
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additional Updates
January 04, 2024
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
December 15, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Sponsors Second Annual International Meeting on Pathway-Related Obesity: Vision & Evidence (IMPROVE) 2023
December 13, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces Updates on MC4R Pathway Programs at R&D Event
December 06, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
November 13, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
November 07, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Receives Positive CADTH Reimbursement Recommendation for IMCIVREE® (setmelanotide)
November 02, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
October 25, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Presents Data from its Long-term Extension Study of Setmelanotide Showing Sustained and Deepened BMI Reduction in Patients with Hypothalamic Obesity at One Year at ObesityWeek® 2023
October 17, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
October 13, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces Six Abstracts to be Presented at The Obesity Society’s Annual Meeting at ObesityWeek ®
October 10, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Presents New Data at ESPE 2023
September 22, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Receives Orphan Drug Designation from European Medicines Agency for Setmelanotide for Treatment of Acquired Hypothalamic Obesity
September 19, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
September 08, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces Update to September Conference Participation
September 08, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome
September 06, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals to Present at Investor Conferences in September
August 28, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces Pre-Marketing Early Access Authorization for Setmelanotide for Use in Patients with Hypothalamic Obesity in France
August 07, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
August 04, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Update
August 01, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome
July 19, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023
July 17, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
July 13, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Presents Data Demonstrating BMI Reduction in Patients with Hypothalamic Obesity Treated with Setmelanotide over Six Months at ENDO 2023
June 17, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
June 07, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
June 06, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals and Genpharm Announce Collaboration to Provide IMCIVREE® (setmelanotide) to Patients in Gulf Cooperation Council Countries
May 22, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® Setmelanotide Injection for Weight Management in Bardet-Biedl Syndrome or Genetically-confirmed Biallelic POMC, PCSK1, or LEPR Deficiency
May 08, 2023
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close